Naz News, Gappers and FLE's

[iconoclassic]

TEVA... TEVA Teva Pharm and Antares announce FDA approval of needle-free injector product for administration of Tev-Tropin (48.60 )

Teva Pharmaceutical Industries and its partner, Antares Pharma (AIS) announced the approval of a Supplemental New Drug Application (sNDA), which added "needle-free injection" to its Tev-Tropin [somatropin (rDNA) for injection] brand human growth hormone drug label. Teva will market the Antares needle-free device as the Tev-Tropin Tjet Injector system.